{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T20:51:42Z","timestamp":1761252702289},"reference-count":34,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.ejphar.2011.05.028","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T15:58:47Z","timestamp":1307116727000},"page":"205-210","source":"Crossref","is-referenced-by-count":5,"title":["Enhanced Angiotensin II type 1 receptor expression in leukocytes of patients with chronic kidney disease"],"prefix":"10.1016","volume":"666","author":[{"given":"Helena","family":"Chon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap A.","family":"Joles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branko","family":"Braam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.05.028_bb0005","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cell.2004.10.006","article-title":"Factor XIIIA transglutaminase crosslinks AT(1) receptor dimers of monocytes at the onset of atherosclerosis","volume":"119","author":"Abdalla","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0010","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1172\/JCI111575","article-title":"Mechanism of sodium modulation of glomerular angiotensin receptors in the rat","volume":"74","author":"Bellucci","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0015","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00041433-200010000-00009","article-title":"Dendritic cells and their involvement in atherosclerosis","volume":"11","author":"Bobryshev","year":"2000","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0020","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2337\/diacare.26.6.1862","article-title":"Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction","volume":"26","author":"Borghi","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00041552-199601000-00015","article-title":"Renal responses to antagonism of the renin\u2013angiotensin system","volume":"5","author":"Braam","year":"1996","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0030","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1161\/01.ATV.0000021412.56621.A2","article-title":"Vascular inflammation and the renin\u2013angiotensin system","volume":"22","author":"Brasier","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0891-5849(97)00104-4","article-title":"Protein carbonyl measurement by a sensitive ELISA method","volume":"23","author":"Buss","year":"1997","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0891-5849(93)90027-R","article-title":"Oxygen-radical absorbance capacity assay for antioxidants","volume":"14","author":"Cao","year":"1993","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0045","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/01.HYP.0000123071.35142.72","article-title":"Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment","volume":"43","author":"Chon","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/01.CIR.86.2.475","article-title":"Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients","volume":"86","author":"Cressman","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.HYP.34.1.113","article-title":"Preactivated peripheral blood monocytes in patients with essential hypertension","volume":"34","author":"Dorffel","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0021-9150(00)00674-2","article-title":"Preactivated monocytes from hypertensive patients as a factor for atherosclerosis?","volume":"157","author":"Dorffel","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(96)06499-6","article-title":"7-ketocholesterol, a specific indicator of lipoprotein oxidation, and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease","volume":"260","author":"Dyer","year":"1997","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0075","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1182\/blood-2002-09-2785","article-title":"Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-kappaB","volume":"102","author":"El Bekay","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0080","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/eurheartj\/ehn138","article-title":"Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up","volume":"29","author":"Guasti","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0085","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.ASN.0000111744.00916.E6","article-title":"The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction","volume":"15","author":"Kaysen","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0090","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.HYP.37.2.587","article-title":"Angiotensin II induces migration and Pyk2\/paxillin phosphorylation of human monocytes","volume":"37","author":"Kintscher","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000076754","article-title":"Effect of angiotensin II type 1 receptor blockade on conduit artery tone in subtotally nephrectomized rats","volume":"96","author":"Koobi","year":"2004","journal-title":"Nephron. Physiol."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1681\/ASN.V111105","article-title":"Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure","volume":"11","author":"Kronenberg","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0105","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0110","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1046\/j.1523-1755.64.s86.12.x","article-title":"Renin\u2013angiotensin system activation and interstitial inflammation in human diabetic nephropathy","author":"Mezzano","year":"2003","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0115","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/hc0402.102619","article-title":"The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part II: AT(1) receptor regulation","volume":"105","author":"Nickenig","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.95.2.473","article-title":"Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells","volume":"95","author":"Nickenig","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0125","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/01.CIR.100.21.2131","article-title":"Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men","volume":"100","author":"Nickenig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0130","first-page":"819","article-title":"The Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET) and combination therapies","volume":"83","author":"Pahor","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0135","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/j.1523-1755.2004.66006.x","article-title":"High calcium diet down-regulates kidney angiotensin-converting enzyme in experimental renal failure","volume":"66","author":"Porsti","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0140","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11745-002-0915-1","article-title":"Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein(a) levels","volume":"37","author":"Scanu","year":"2002","journal-title":"Lipids"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0145","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/01.HYP.28.3.403","article-title":"Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat","volume":"28","author":"Sechi","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0150","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.HYP.0000144480.10207.34","article-title":"Primed polymorphonuclear leukocytes, oxidative stress, and inflammation antecede hypertension in the Sabra rat","volume":"44","author":"Sela","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0021-9150(98)00021-5","article-title":"Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys","volume":"138","author":"Song","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2011.05.028_bb0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000063511","article-title":"Renoprotective mechanisms of angiotensin II antagonism in experimental chronic renal failure","volume":"25","author":"Uhlenius","year":"2002","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0165","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1681\/ASN.V103545","article-title":"Angiotensin II receptor type 1 gene expression in human glomerulonephritis and diabetes mellitus","volume":"10","author":"Wagner","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2011.05.028_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911005966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911005966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T15:04:15Z","timestamp":1637766255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911005966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":34,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0014299911005966"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.05.028","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}